Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Aug 31;112(35-36):577-84.
doi: 10.3238/arztebl.2015.0577.

The Treatment of Primary Breast Cancer in Older Women With Adjuvant Therapy: A Retrospective Analysis of Data From Over 3000 Patients From the PATH Biobank, With Two-Year Follow-up

Elke Peters  1 , Tobias Anzeneder, Christian Jackisch, Thomas Dimpfl, Georg Kunz, Alexander Katalinic, Annika Waldmann
Affiliations

The Treatment of Primary Breast Cancer in Older Women With Adjuvant Therapy: A Retrospective Analysis of Data From Over 3000 Patients From the PATH Biobank, With Two-Year Follow-up

Elke Peters et al. Dtsch Arztebl Int. .

Abstract

Background: Breast cancer is the most common cancer in women in Germany. Mortality from breast cancer has declined over the past 15 years, but less so in women aged 70 or older than in younger women. The discrepancy might be explained by age-related differences in treatment.

Methods: Data from the Patients' Tumor Bank of Hope (PATH) database of women who underwent adjuvant treatment for the treatment of an invasive primary tumor without distant metastases (year of diagnosis, 2006-2011) were retrospectively analyzed. The clinical and tumor-biological findings and treatment data over two years of follow-up were compared across three age groups (under age 50, ages 50 to 69, and ages 70 and up). Chi-square tests were carried out to reveal significant differences, and post-hoc multiple comparisons were performed with and without Bonferroni correction. Treatment data were adjusted for staging and grading and tested for age-dependence with logistic regression.

Results: Follow-up data were available for 3257 (65% ) of 4981 women, of whom 61% were in the middle age group and 22% in the oldest. Compared to women aged 50 to 69, those aged 70 and up less commonly received breast-conserving treatment (68.8% vs. 86.4% ), chemotherapy (27.5% vs. 44.1% ), radiotherapy (81.8% vs. 92.4% ), and trastuzumab (52.9% vs. 79.3% ; p<0.001 for all differences). All differences remained significant after stastistical adjustment.

Conclusion: The cause of these age-related differences is unclear. It cannot be determined from these data whether concomitant disease, the older patients' individual decisions, or other factors were responsible for their not receiving treatment as often as the younger patients did.

PubMed Disclaimer

Figures

Figure
Figure
Proportion of women treated with radiotherapy and chemotherapy by age group. The figure shows 95% confidence intervals and significant differences after Bonferroni correction
See this image and copyright information in PMC

Comment in

References

    1. RKI, GEKID. Ausgabe. Berlin: Robert Koch-Institut und die Gesellschaft der epidemiologischen Krebsregister in Deutschland; 2013. Krebs in Deutschland 2009/2010. 9.
    1. RKI. Brustkrebs (Mammakarzinom) www.rki.de/Krebs/DE/Content/Krebsarten/Brustkrebs/brustkrebs_node.html. 2012. (last accessed 18 May 2015)
    1. Early Breast Cancer Trialists’ Collaborative G. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005;365:1687–1717. - PubMed
    1. Jackisch C, Funk A, König K, Lubbe D, Misselwitz B, Wagner U. Disease management project breast cancer in Hesse - 5-year survival data: successful model of intersectoral communication for quality assurance. Geburtshilfe Frauenheilkd. 2014:276–283. - PMC - PubMed
    1. Untch M, Jackisch C, Thomssen C, Nitz U, Minckwitz Gv, Kaufmann M. Adjuvant treatment with Trastuzumab in patients with breast cancer. Dtsch Arztebl. 2006;103:3406–3410.

Publication types

MeSH terms

Substances